Veradermics, Incorporated (MANE) is listed on NYSE in Pharmaceutical Stocks. It is $98.02, -3.72%, with a $4.1B market cap. RSI is 39.9, near oversold. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 39.9 Near Oversold
Market Cap $4.1B
Volume 406.7K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-50.7M
EPS $-1.69
P/E Ratio -58.0x
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Montanova Capital, LLC | Insider | Sell | 750,000 | $107.25 | $80.4M | 2026 Aug 19 |
| Durso Timothy August | Chief Technical Officer | Sell | 43,500 | $107.82 | $4.7M | 2026 Aug 17 |
| Waldman Reid Alexander | Chief Executive Officer | Sell | 67,500 | $107.86 | $7.3M | 2026 Aug 17 |
| Childs John W | Director | Sell | 100,000 | $107.12 | $10.7M | 2026 Aug 12 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $29.12 | 56.8 | $5.0B |
| | $25.07 | 48.2 | $4.7B |
Take MANE further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put MANE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Veradermics, Incorporated next reports.
Set alerts on MANE
Get notified when Veradermics, Incorporated hits your price targets or technical conditions are met.
Get Started Free